The antitumor effects of chronic tirzepatide treatment in obese mice, on colon and breast cancer models are consistent with our findings in a murine model of endometrial cancer 30 , as well as a report by others on liver cancer 36 , and are further supported by reports that significant weight loss (at levels similar to those achieved with tirzepatide) in response to chronic or intermittent calorie restriction or bariatric surgery have anticancer effects in multiple obesity-related cancer models 4446
10.4161/cc.20598 Summary Keywords breast cancer, angiogenesis, tumor vasculature, VEGF, tyrosine kinase inhibitor (TKI), resistance Citation Ayoub NM, Jaradat SK, Al-Shami KM and Alkhalifa AE (2022) Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches
High-dose semaglutide reduced an average of 17-18 percent of body weight from baseline after 68 weeks in global phase 3 STEP trials, proving better effect than Saxenda
For the majority of individuals, experiencing hair loss while on tirzepatide does not necessitate discontinuing the medication
It depends on the company
Nayan Patel, Chief Scientific Officer of ThriveLab and the author of The Glutathione Revolution
